ISCHEMIC COMPLICATIONS OF TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN LIVER MALIGNANCIES
|
|
- Stephanie Carter
- 5 years ago
- Views:
Transcription
1 Acta Radiologica 41 (2000) Copyright C Acta Radiologica 2000 Printed in Denmark All rights reserved ACTA RADIOLOGICA ISSN ISCHEMIC COMPLICATIONS OF TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN LIVER MALIGNANCIES P. G. TARAZOV 1,V.N.POLYSALOV 2,K.V.PROZOROVSKIJ 3,I.V.GRISHCHENKOVA 4 and E. V. ROZENGAUZ 3 1 Division of Angio/Interventional Radiology, 2 Department of Hepatic Surgery, 3 Department of Roentgenology and 4 The Intensive Care Unit, St. Petersburg Research Institute of Roentgenology and Radiation Therapy, St. Petersburg, Russia. Abstract Objective: To determine the frequency, character, methods of treatment, and Key words: Liver neoplasms, outcome of ischemic complications after transcatheter hepatic artery chemoem- chemoembolization; interventional bolization (TACE). procedures, therapeutic. Material and Methods: Between 1985 and 1998, 827 sessions of TACE with Doxorubicin mixed with iodized oil, and gelatin sponge particles were per- Correspondence: Pavel G. Tarazov, formed in 282 patients with primary and metastatic liver cancer. Post-TACE Research Institute of Roentgenology, monitoring included clinical observation, US and CT. ul. Leningradskaja 70/4, Pesochny-2, Results: Ischemic complications appeared in 13 (4.6%) and included the fol- St. Petersburg, RU Russia. lowing: hepatic (nω6) and splenic abscess (nω1), cholecystitis (nω3), and bile FAX π duct necrosis (nω3). The treatment was US-guided drainage in 12 cases and systemic antibacterial therapy in 1. No negative influence of these complications Accepted for publication 22 October on survival of patients was detected Conclusion: Serious ischemic complications of TACE occur in about 5% of patients and can be successfully managed without open surgery. These complications do not worsen the survival of patients. Transcatheter arterial chemoembolization (TACE) is widely applied in palliative treatment of unresectable primary and metastatic cancer of the liver (5, 6). The rationale for TACE is based on a dual blood supply of liver parenchyma from the hepatic artery and the portal vein and the predominantly arterial supply of tumors. The combination of intraarterial injection of a chemotherapeutic agent mixed with iodized oil and arterial embolization allows the achievement of maximal tumor response (2). However, TACE sometimes brings about ischemic complications such as cholecystitis, pancreatitis, bile duct necrosis, liver and splenic abscess (2, 4, 7 17). The purpose of this retrospective study was to analyze the frequency, severity, methods of treatment and outcome of these complications. Material and Methods Between 1985 and 1998, 827 TACE procedures (range 1 12, mean 3.9 per patient) were performed in 282 patients with unresectable primary (nω80) and metastatic (nω202, mainly from colorectal cancer) liver malignancies. The primary tumors were 5 to 30 cm in diameter with 2 to multiple daughter nodules. Tumors 2 to 10 cm in diameter affecting both liver lobes were detected in all cases of metastases. Angiography and TACE were carried out as follows: The Seldinger technique was used for catheterization of the femoral or axillary artery. Pretreatment celiac and superior mesenteric arteriography using mm ( F) selective visceral catheters was performed to define hepatic 156
2 ISCHEMIC COMPLICATIONS OF TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION Table Clinical summary of patients with post-tace ischemic complications Complication, Morphological diagnosis of Outcome, No./Sex/Age liver tumor survival (months) Liver abscess 1/F/65 colorectal metastases died (23) 2/M/66 colorectal metastases died (19) 3/M/60 colorectal metastases died (21) 4/F/50 metastases from uterine died (14) carcinoma 5/M/44 carcinoid metastases died (28) 6/M/27 carcinoid metastases remission (114) Cholecystitis 7/M/59 colorectal metastases progression (18) 8/M/40 colorectal metastases died (39) 9/F/51 hepatocellular carcinoma remission (108) Bile duct necrosis 10/M/56 metastases from gastric cancer progression (60) 11/M/52 colorectal metastases remission (7) 12/M/45 colorectal metastases remission (6) Splenic abscess 13/F/14 recurrent hepatoblastoma died (31) vascular anatomy, volume and location of the tumor, and portal vein patency. The proper hepatic artery was then selectively catheterized with the same catheter. If both lobes of the liver were affected, the treatment was performed by separate selective right hepatic and left hepatic TACE with a 1- to 2-week interval. When possible, the tip of the catheter was placed distal to the cystic artery. Intrahepatic injection of mg Doxorubicin (Pharmacia-Upjohn) mixed with 10 ml Lipiodol Ultrafluid (Guerbet) was followed by hepatic artery occlusion with 1 1 mm cubes or 1 5 mm torpedoes of Gelfoam (Pharmacia-Upjohn). Then 80 to 160 mg Gentamicin was added to the embolization mixture. Post-TACE monitoring included clinical observation, laboratory analyses, US and CT. tion of a solitary abscess with a diameter of 3 cm and 5 cm, while in the each of 2 other patients, 2 abscesses of approximately the same size were revealed. Two remaining patients had a single abscess involving both the tumor nodules and the normal parenchyma. The treatment included percutaneous US-guided puncture and subsequent drainage by one or two silicon tubes of 3 5 mm diameter with lavage of the abscess cavity by solutions of antiseptics and antibiotics during 8 22 days. After removal of the drainage tubes the residual cavity decreased slowly and disappeared within 3 months. Ischemic cholecystitis (nω3) and cholangitis (nω 3) were also successfully treated with percutaneous US-guided drainage of the gallbladder or bile ducts, respectively, and systemic antibiotics (cases 7 12, Table, Fig.). Subsequent US and CT investigations showed shrinkage of the gallbladder without formation of gallstones. In the patient with destructive cholangitis (case 10, Table), no bile cysts were seen on subsequent US and CT. The formation of several small (2 4 mm) splenic abscesses developed in 1 patient (case 11, Table). This complication was successfully managed with 1-week systemic antibiotic therapy. Two months later, US and CT showed normal parenchyma of the spleen. In the retrospective analysis, there was no correlation of development of infectious ischemic complications with the dose of chemotherapeutic drug and iodized oil, number of procedures, or volume of TACE and the embolized tumor. At present (October 1999), 6 patients are still alive. Of those, 2 patients, 1 with hepatocellular carcinoma (case 9, Table) and 1 with carcinoid liver Results Serious ischemic complications developed in 13 (4.6%) patients including 11 with liver metastases and 2 with primary hepatic tumors (Table). All complications were symptomatic with local pain, fever, leukocytosis, and were diagnosed by US and/ or CT 7 25 days after the first (nω8), second, third (each nω2) and fifth (nω1) TACE. Liver abscess in the embolized liver lobe occurred in 6 patients (cases 1 6, Table). The lesion was located in the non-tumorous liver parenchyma in 4 patients. Of those, 2 patients developed forma- Figure. PTC shows bile duct necrosis with formation of multiple bilomas after TACE (case 10). 157
3 P. G. TARAZOV ET AL. metastases (case 6, Table) had remission of disease during 9 and 12 years, respectively. Two other patients with colorectal and gastric cancer metastases, respectively, showed tumor progression at 18 and 60 months post-tace (cases 7 and 10, Table). Remission for 6 and 7 months was noted in 2 other patients (cases 11 and 12, Table). Seven patients died (mean ) months after TACE (Table). Discussion Serious ischemic complications of TACE are relatively rare. According to the literature, their frequency constitutes 3 12% (1, 3, 16). In our group, these complications occurred in 4.6% of patients, or in 1.6% of the procedures. The cause of necrotic changes in organs adjacent to the liver is the ischemia after inadvertent embolization of arteries, supplying the gallbladder, bile ducts, pancreas and spleen (2, 8, 11 15, 21). However, these aseptic necroses are usually small and do not require invasive treatment (1, 2, 5, 10). The risk factors for development of post-tace complications include (6, 14 19, 22) the following: a) non-selective placement of the catheter during TACE; b) high doses of cytostatics and iodized oil used in TACE; c) use of the small-diameter embolic agents; d) liver functional disorders; e) previous surgery on the liver and bile ducts; and f) obstruction of the bile ducts and/or portal vein branches. The question of preventive application of antibacterial drugs in TACE remains unsolved. REED et al. have urgently recommended supplement of antibiotics in the embolization mixture (20). On the other hand, ALLISON et al., despite of antibacterial therapy, have observed 2 cases of sepsis and 2 liver abscesses in 4 of 57 patients (1), whereas CHUANG & CHARNSANGAVEJ have noted similar complications only in 3 of more than 1,000 patients after embolization without antibiotics (5). On the basis of transcatheter treatment of 61 patients with hepatocellular carcinoma, CASTELLS et al. stated that antibiotic prophylactics are not necessary for TACE (3). Previously, we also found that post-tace complications arise approximately equally in groups of patients receiving and not receiving antibacterial therapy (26). In our opinion, prophylactic antibacterial therapy should not be used routinely but probably may be indicated in patients with the above-mentioned risk factors. Liver abscess. The occurrence of gas within the embolized tumor is a frequent finding at subsequent CT. This phenomenon is explained by tumor necrosis, air in the hepatic artery during the procedure, and also vital activity of a gas-producing microflora (5, 22). The formation of true abscess is rare. CHUNG et al. noted this complication only in 1 of 350 cases, DE BAERE et al. in 4 of 489, and CHEN et al. in 5 of 289 patients after TACE (4, 6, 8). The clinical and radiologic symptoms of liver abscesses are well known. Surgical (more often in large and multiple abscesses) or percutaneous treatment is usually successful (4, 25). However, in cases complicated by sepsis, the outcome can be fatal (9, 18). In all our liver abscess patients (cases 1 6), the doses of cytostatic-in-oil used for TACE were within the standard limits, and occlusion of the hepatic artery was performed with relatively large (2 mm) gelatin sponge particles. Prophylactic antibiotics were used in 3 of 4 cases. Nevertheless, ischemic infarction of the liver with formation of abscess occurred. These data confirm the opinion that development of liver abscess after TACE is infrequent but almost unpredictable (9, 12). Iodized oil in the portal vein after TACE and previous bilioenteric anastomosis are major risk factors. Also patients with carcinoid liver metastases are more inclined to provoke necrotico-infectious complications (8, 25). Ischemic cholecystitis. Signs of acute cholecystitis such as local pain at the site of the gallbladder with thickening of its walls is seen on US in 11 45% of patients post-tace (14, 24). These symptoms are usually resolved after conservative therapy (5, 6, 16). However, it is necessary to take into account, that these patients have a subsequent risk of cholelithiasis. Therefore, if hepatic resection is executed after TACE, the gallbladder also should be removed (14). Gangrenous post-tace cholecystitis develops in 1 2% of patients and requires invasive treatment which can vary from open or laparoscopic cholecystectomy to percutaneous US- or CT-guided drainage (16, 23, 27). The main prophylaxis of this complication is placement of the catheter distal to the cystic artery and avoidance of reflux during TACE (5, 24). However, distal catheterization is sometimes technically impossible because of tortuosity of the hepatic artery or impossibility of identification of visceral arteries (14, 15). Also, reflux of non-contrast particles can be missed even in cases of appropriate placement of the catheter (16). We performed TACE proximally to the cystic artery in 2 of 3 patients who developed ischemic cholecystitis. In case 7, distal catheterization attempts were unsuccessful even with the use of a microcatheter. In case 8, several hepatic arterial branches 158
4 ISCHEMIC COMPLICATIONS OF TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION supplying the tumor arose proximal to the cystic artery. In the remaining case 9, probably inadvertent embolization appeared. Treatment with percutaneous US-guided drainage was successful in all 3 patients with ischemic cholecystitis. Bile duct necrosis. It is known, that in contrast to the normal liver parenchyma, the bile ducts do not have any dual blood supply and are fed exclusively from the hepatic artery. Therefore ischemia of the biliary tree of some degree inevitably develops after TACE (14, 15). However, clinical symptoms rarely occur. The risk of ischemic cholangitis with bile duct necrosis and formation of bilomas increases when liquid (ethanol) or small (Gelfoam or Ivalon powder) embolic agents are used (2, 17, 21). The complication is usually systemically treated with antibiotics (17). Our patients with bile duct necrosis (cases 10 12) had multiple necroses with development of bilomas and rise of blood serum bilirubin level up to mmol/l, which made percutaneous biliary drainage necessary. Splenic abscess. The cause of this complication is inadvertent embolization through arterial collaterals between the liver and spleen or because of unintentional reflux (3). Droplets of iodized oil have sometimes been found in the spleen after TACE. Fortunately, most of these patients show no clinical symptoms. In rare cases of large splenic abscess formation, surgical splenectomy or percutaneous drainage is indicated. This complication developed in patient 11 with the post-resection recurrent hepatoblastoma and could be provoked by presence of collaterals between the liver and the spleen. Small abscesses located at the upper pole of the spleen resolved after systemic antibiotic therapy. Survival. The survival rate of patients after complicated TACE has not been studied before. The present data showed that the long-term results of TACE in these patients were close to those of patients who had no complications. Moreover, in cases 6, 9, and 10, a 12-, 9- and 5-year survival was achieved. Conclusion. Serious ischemic complications of TACE occur in about 5% of patients and can be successfully treated by percutaneous technique in most cases. The survival rate of these patients is not worse than that of patients who have uncomplicated TACE. REFERENCES 1. ALLISON D. J., JORDAN H. & HENNESY O.: Therapeutic embolization of the hepatic artery. A review of 75 procedures. Lancet 1 (1985), BERGER D. H., CARRASCO C. H., HOHN D. C. & CURLEY S. A.: Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors. Post-treatment management and complications. J. Surg. Oncol. 60 (1995), CASTELLS A., BRUIX J., AYUSO C. et al.: Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolic fever. J. Hepatol. 22 (1995), CHEN C., CHEN P.-J., YANG P.-M. et al.: Clinical and microbiological features of liver abscess after transcatheter embolization for hepatocellular carcinoma. Am. J. Gastroenterol. 92 (1997), CHUANG V. P. & CHARNSANGAVEJ C.: Complications of hepatic arterial embolization and chemoembolization. Treatment and prevention. Semin. Intervent. Radiol. 11 (1994), CHUNG J. W., PARK J. H., HAN J. K. et al.: Hepatic tumors. Predisposing factors for complications of transcatheter oily chemoembolization. Radiology 198 (1996), COHEN S. E., SAFADI R., VERSTROMDIG A. et al.: Liverspleen infarcts following transcatheter chemoembolization. A case report and review of the literature on adverse effects. Dig. Dis. Sci. 42 (1997), DE BAERE T., ROCHE A., AMENABAR J. M. et al.: Liver abscess formation after local treatment of liver tumors. Hepatology 23 (1996), GERSON L. B., PONT A. & CUMMINS R. T.: Clostridial bacteremia and death following chemoembolization for hepatocellular carcinoma. J. Vasc. Intervent. Radiol. 5 (1994), GOTOH M., MONDEN M., SAKOH M. et al.: Bile duct necrosis after partial hepatectomy and transcatheter hepatic artery embolization (letter). AJR 154 (1990), HASHIMOTO T., MITANI T., NAKAMURA H. et al.: Fatal septic complication of transcatheter chemoembolization for hepatocellular carcinoma. Cardiovasc. Intervent. Radiol. 16 (1993), ICHIKAWA T., YAMADA T., TAKAGI H. et al.: Transcatheter arterial embolization-induced bilious pleuritis in a patient with hepatocellular carcinoma. J. Gastroenterol. 32 (1997), INOUE Y., NAKAMURA H., TAKASHIMA S. et al.: Biloma following transcatheter oily chemoembolization. Radiat. Med. 9 (1991), JENG K.-S. & CHIANG H.-J.: Delayed formation of gallstones after transcatheter arterial embolization for hepatocellular carcinoma. Is elective cholecystectomy advisable during hepatectomy? Arch. Surg. 124 (1989), KOBAYASHI S., NAKANUMA Y., TERADA T. & MATSUI O.: Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy. Relevance to microvascular damages of peribiliary capillary plexus. Am. J. Gastroenterol. 88 (1993), KURODA C., IWASAKI M., TANAKA T. et al.: Gallbladder infarction following hepatic transcatheter arterial embolization. Radiology 149 (1993), MAKUUCHI M., SUKIGARA M., MORI T. et al.: Bile duct necrosis. Complication of transcatheter hepatic arterial embolization. Radiology 156 (1985), MARLINK R. G., LOKICH J. J., ROBINS J. R. & CLOUSE M. E.: Hepatic arterial embolization for metastatic hormonesecreting tumors. Cancer 65 (1990), NISHIDA N., YAMADA R., KISHI K. et al.: Dose-dependence of hepatocellular necrosis in a canine model of chemoembolization. J. Vasc. Intervent. Radiol. 5 (1994), REED R. A., TEITELBAUM G. P., DANIELS J. R., PENTECOST M. J. & KATZ M. D.: Prevalence of infection following hepatic chemoembolization with cross-linked collagen with 159
5 P. G. TARAZOV ET AL. administration of prophylactic antibiotics. J. Vasc. Intervent. Radiol. 5 (1994), RICHARDET J.-P., LONS T., SIBONY M. et al.: Cholangite sclerosante secondaire et chimio-embolisation Lipiodolee. Gastroenterol. Clin. Biol. 18 (1994), SIIM E.&FLECKENSTEIN P.: Gas formation following hepatic tumor embolization. Br. J. Radiol. 55 (1982), SIMONS R. K., SINANAN M. N. & COLDWELL D. M.: Gangrenous cholecystitis as a complication of hepatic artery embolization. Surgery 112 (1992), TAKAYASU K., MORIYAMA N., MURAMATSU Y. et al.: Gall- bladder infarction after hepatic artery embolization. AJR 144 (1985), TARAZOV P. G.: Iodized oil in the portal vein after arterial chemoembolization of liver metastases a caution regarding hepatic necrosis. Acta Radiol. 35 (1994), TARAZOV P. G.: Hepatic chemoembolization. Are prophylactic antibiotics necessary? (letter). J. Vasc. Intervent. Radiol. 6 (1995), YEUNG E., JACKSON J., FINN J. P. et al.: Acalcalous cholecystitis complicating hepatic intraarterial Lipiodol. Cardiovasc. Intervent. Radiol. 12 (1989),
6 Copyright of Acta Radiologica is the property of Royal Society of Medicine Press Limited and its content may not be copied or ed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or articles for individual use.
MDCT findings after hepatic chemoembolization with DC-beads: What the radiologist needs to know
Abdominal Imaging ª Springer Science+Business Media New York 2012 Published online: 10 October 2012 Abdom Imaging (2013) 38:778 784 DOI: 10.1007/s00261-012-9963-6 MDCT findings after hepatic chemoembolization
More informationInterventional Radiology in Liver Cancer. Nakarin Inmutto MD
Interventional Radiology in Liver Cancer Nakarin Inmutto MD Liver cancer Primary liver cancer Hepatocellular carcinoma Cholangiocarcinoma Metastasis Interventional Radiologist Diagnosis Imaging US / CT
More informationTransarterial chemoembolization (TACE), which involves
J Clin Gastroenterol 2001;32(5):423 427. 2001 Lippincott Williams & Wilkins, Inc. Ischemic Bile Duct Injury as a Serious Complication After Transarterial Chemoembolization in Patients with Hepatocellular
More informationStaging & Current treatment of HCC
Staging & Current treatment of HCC Dr.: Adel El Badrawy Badrawy; ; M.D. Staging & Current ttt of HCC Early stage HCC is typically silent. HCC is often advanced at first manifestation. The selective ttt
More informationLiver Abscess After Transarterial Chemoembolization in Patients With Bilioenteric Anastomosis: Frequency and Risk Factors
Vascular and Interventional Radiology Original Research Woo et al. Liver Abscess After Transarterial Chemoembolization Vascular and Interventional Radiology Original Research Sungmin Woo 1 Jin Wook Chung
More informationHepatocellular Carcinoma Rupture after Transcatheter Arterial Chemoembolization
Chin J Radiol 2004; 29: 41-45 41 Hepatocellular Carcinoma Rupture after Transcatheter Arterial Chemoembolization KUNG-SHIH YING 1 SHYUH-HUEI HUANG 2 CHE-JEN CHAO 3 SHIN-HWA WU 1 TAI-YU CHANG 1 CHUNG-HSEIN
More informationLin Yang, Xiao Ming Zhang, Yong Jun Ren, Nan Dong Miao, Xiao Hua Huang, and Guo Li Dong
Radiology Research and Practice Volume 2013, Article ID 535272, 6 pages http://dx.doi.org/10.1155/2013/535272 Clinical Study The Features of Extrahepatic Collateral Arteries Related to Hepatic Artery Occlusion
More informationTransarterial Chemoembolization in Neuroendocrine Liver Metastasis
Transarterial Chemoembolization in Neuroendocrine Liver Metastasis Ricardo D. Garcia-Monaco, MD, PhD, FSIR; Andres Alejandro Kohan, MD From Vascular and Interventional Radiology, Department of Radiology,
More informationLarge Nonmalignant Hepatic Mass and Role of Pediatric Interventional Radiology
Originally Posted: December 18, 2014 Large Nonmalignant Hepatic Mass and Role of Pediatric Interventional Radiology Resident(s): Kushal R Parikh, MD Attending(s): Jonathan R Dillman, MD and Ranjith Vellody,
More informationBacterial Infections Associated with Hepatic Arteriography and Transarterial Embolization for Hepatocellular Carcinoma: A Prospective Study
161 Bacterial Infections Associated with Hepatic Arteriography and Transarterial Embolization for Hepatocellular Carcinoma: A Prospective Study Chiher Chen, Yuk-Ming Tsang, Po-Ren Hsueh, Guan-Tarn Huang,
More informationHepatobiliary Malignancies Retrospective Study at Truman Medical Center
Hepatobiliary Malignancies 206-207 Retrospective Study at Truman Medical Center Brandon Weckbaugh MD, Prarthana Patel & Sheshadri Madhusudhana MD Introduction: Hepatobiliary malignancies are cancers which
More informationPost-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options
Post-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options Poster No.: C-1501 Congress: ECR 2015 Type: Educational Exhibit Authors: A. Hadjivassiliou,
More informationTreatment of Hepatocellular Carcinoma. Andrew J. Muir, MD MHS Division of Gastroenterology Duke University Medical Center
Treatment of Hepatocellular Carcinoma Andrew J. Muir, MD MHS Division of Gastroenterology Duke University Medical Center Epidemiology of HCC: world The 5 th most common cancer worldwide > 500, 000 new
More informationHepatocellular Carcinoma: Diagnosis and Management
Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm
More informationFatal Bile Duct Necrosis: A Rare Complication of Transcatheter Arterial Chemoembolization in a Patient with Endocrine Hepatic Metastasis
356 Fatal Bile Duct Necrosis: A Rare Complication of Transcatheter Arterial Chemoembolization in a Patient with Endocrine Hepatic Metastasis Anne-Laure Pelletier a Pascal Hammel a Magali Zappa b Pierre
More informationCHEMOEMBOLISATION USING IODIZED OIL(LIPIODOL ) BASED TECHNIQUES
CHEMOEMBOLISATION USING IODIZED OIL(LIPIODOL ) BASED TECHNIQUES Peter Huppert Department of Radiology, Neuroradiology and Nuclear Medicine Klinikum Darmstadt ATH Universities of Frankfurt and Heidelberg/Mannhein
More informationGut Online First, published on May 5, 2005 as /gut
Gut Online First, published on May 5, 2005 as 10.1136/gut.2005.069237 p53 gene (Gendicine ) and embolization overcame recurrent hepatocellular carcinoma Guan YS, Liu Y, Zhou XP, Li X, He Q, Sun L. Authors
More informationPolyvinyl Alcohol Embolization Adjuvant to Oily Chemoembolization in Advanced Hepatocellular Carcinoma with Arterioportal Shunts
Polyvinyl Alcohol Embolization Adjuvant to Oily Chemoembolization in Advanced Hepatocellular Carcinoma with Arterioportal Shunts Yeo Ju Kim, MD 1 Hae Giu Lee, MD 1 Jeong Mi Park, MD 2 Yeon Soo Lim, MD
More informationVisceral aneurysm. Diagnosis and Interventions M.NEDEVSKA
Visceral aneurysm Diagnosis and Interventions M.NEDEVSKA History 1953 De Bakeyand Cooley Visceral aneurysm VAAs rare, reported incidence of 0.01 to 0.2% on routine autopsies. Clinically important Potentially
More informationSpinal Cord Ischemia Secondary to Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
Published online: September 10, 2014 1662 0631/14/0083 0264$39.50/0 This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC)
More informationSuperselective vs. lobar transarterial ethiodized oil-chemoembolization - occurrence and clinical significance of non-target embolization
Superselective vs. lobar transarterial ethiodized oil-chemoembolization - occurrence, p. 13-22 Interventional HR J Original Article Superselective vs. lobar transarterial ethiodized oil-chemoembolization
More informationInterventional Radiology in Trauma. Vikash Prasad, MD, FRCPC Vascular and Interventional Radiology The Moncton Hospital
Interventional Radiology in Trauma Vikash Prasad, MD, FRCPC Vascular and Interventional Radiology The Moncton Hospital Disclosures None relevant to this presentation Shareholder Johnson and Johnson Goal
More informationNYU School of Medicine Department of Radiology Rotation-Specific House Staff Evaluation
Vascular & Interventional Radiology Rotation 1 Core competency in vascular and interventional radiology during the first resident rotation consists of clinical objectives, technical objectives and image
More informationIntra-arterial Therapy in Management of HCC: ctace, DEB-TACE, and Y90 Radioembolization
Intra-arterial Therapy in Management of HCC: ctace, DEB-TACE, and Y90 Radioembolization Department of Radiology, National Cancer Center In Joon Lee Contents Conventional TACE Role of TACE in management
More informationImaging of liver and pancreas
Imaging of liver and pancreas.. Disease of the liver Focal liver disease Diffusion liver disease Focal liver disease Benign Cyst Abscess Hemangioma FNH Hepatic adenoma HCC Malignant Fibrolamellar carcinoma
More information6 th August 2018 Day 1 - Gallbladder & Bile duct Topic
Venue: Sterling Hospital Auditorium, Sterling Hospitals, Gurukul Road Ahmedabad, Gujarat 6 th August 2018 Day 1 - Gallbladder & Bile duct Registration(8:00am-8:15am) Inauguration(8:15am-8:30am) Welcome
More informationTips and tricks. Camillo Aliberti, Massimo Tilli
Tips and tricks Camillo Aliberti, Massimo Tilli Unit of Oncological Diagnostic and Interventional Radiology, Delta Hospital AUSL Ferrara, Ferrara Italy camy.ali@libero.it mtilli72@libero.it Intra-arterial
More informationTrans-arterial radioembolisation (TARE) of unresectable HCC using Y-90 microspheres: is it dangerous in case of portal vein thrombosis?
Trans-arterial radioembolisation (TARE) of unresectable HCC using Y-90 microspheres: is it dangerous in case of portal vein thrombosis? Poster No.: C-1634 Congress: ECR 2014 Type: Authors: Keywords: DOI:
More informationPercutaneous biliary drainage: complications and efficiency at short and mean terms: about 50 cases
Percutaneous biliary drainage: complications and efficiency at short and mean terms: about 50 cases Poster No.: C-1497 Congress: ECR 2016 Type: Scientific Exhibit Authors: M. Matri, L. Ben Farhat, I. Marzouk
More informationJin Wook Chung, MD 1 Hyo-Cheol Kim, MD 1 Jung-Hwan Yoon, MD 2 Hyo-Suk Lee, MD 2 Hwan Jun Jae, MD 1 Whal Lee, MD 1 Jae Hyung Park, MD 1
Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Prevalence and Causative Factors of Extrahepatic Collateral Arteries in 479 Patients Jin Wook Chung, MD 1 Hyo-Cheol Kim, MD 1 Jung-Hwan
More informationSTRICTURES OF THE BILE DUCTS Session No.: 5. Andrea Tringali Digestive Endoscopy Unit Catholic University Rome - Italy
STRICTURES OF THE BILE DUCTS Session No.: 5 Andrea Tringali Digestive Endoscopy Unit Catholic University Rome - Italy Drainage of biliary strictures. The history before 1980 Surgical bypass Percutaneous
More informationREFERRAL GUIDELINES: GALLSTONES
REFERRAL GUIDELINES: GALLSTONES Document Purpose To ensure patients with gallstones disease are managed appropriately in primary/ secondary care Oxford Radcliffe Hospital Surgical Department Surgical Registrar
More informationPhase II Study of Chemoembolization with Drug-eluting Beads in Patients with Hepatic. Neuroendocrine Metastases: Interim Analysis
Phase II Study of Chemoembolization with Drug-eluting Beads in Patients with Hepatic Neuroendocrine Metastases: Interim Analysis Original research Advances in knowledge: 1. The incidence of biloma and
More informationVascular complications in percutaneous biliary interventions: A series of 111 procedures
Vascular complications in percutaneous biliary interventions: A series of 111 procedures Poster No.: C-0744 Congress: ECR 2013 Type: Educational Exhibit Authors: A. BHARADWAZ; AARHUS, Re/DK Keywords: Obstruction
More informationA Metastatic Adrenal Tumor from a Hepatocellular Carcinoma: Combination Therapy with Transarterial
A Metastatic Adrenal Tumor from a Hepatocellular Carcinoma: Combination Therapy with Transarterial Chemoembolization and Radiofrequency Ablation 1 Hyun-Jin Lim, M.D., Yun Ku Cho, M.D., Yong-Sik Ahn, M.D.,
More informationTRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD
UNIVERSITY OF PRETORIA STEVE BIKO ACADEMIC HOSPITAL SOUTH AFRICA TRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD 1 INTRODUCTION Hepatic
More informationSurgical Workload, Outcome and Research Database: V1.1
Technical Guidance for Surgical Workload, Outcome and Research Database: V1.1 Contents 1. Standard Indicators... 5 1.1. Activity Volume... 5 1.2. Average Length of Stay (Days)... 5 1.3. 2/7/30 day Re-admission
More informationIntra arterial ports: complex, demanding but rewarding
Intra arterial ports: complex, demanding but rewarding Gregory Amouyal, MD. Marc sapoval, MD. PhD. Olivier Pellerin, MD. MsC. Interventional Radiology Department, hospital European Georges Pompidou, Paris,
More informationYttrium-90 Radioembolization of Malignant Tumors of the Liver: Gallbladder Effects
Vascular and Interventional Radiology Original Research Sag et al. Radioembolization of Liver Tumors Vascular and Interventional Radiology Original Research Alan A. Sag 1 Michael A. Savin 2 Nirish R. Lal
More informationGeneral summary GENERAL SUMMARY
General summary GENERAL SUMMARY In Chapter 2.1 the long-term results and prognostic factors of radiofrequency ablation (RFA) for unresectable colorectal liver metastases (CRLM) in a single center with
More informationLocoregional Treatments for HCC Applications in Transplant Candidates. Locoregional Treatments for HCC Applications in Transplant Candidates
Locoregional Treatments for HCC Applications in Transplant Candidates Matthew Casey, MD March 31, 2016 Locoregional Treatments for HCC Applications in Transplant Candidates *No disclosures *Off-label uses
More informationRadioembolization with Lipiodol for the Treatment of Hepatocellular Carcinoma and Liver Metastases
Radioembolization with Lipiodol for the Treatment of Hepatocellular Carcinoma and Liver Metastases Pr Francesco Giammarile CHLS Lyon Faculté de Lyon Sud «Aut tace aut loquere meliora silentio» Malignant
More informationA case of necrotizing pancreatitis subsequent to transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma
pissn 2287-2728 eissn 2287-285X Case Report Clinical and Molecular Hepatology 2012;18:321-325 A case of necrotizing pancreatitis subsequent to transcatheter arterial chemoembolization in a patient with
More informationRegional Therapy for Metastatic Neuroendocrine Tumors. Janette Durham, MD Professor of Radiology University of Colorado School of Medicine
Regional Therapy for Metastatic Neuroendocrine Tumors Janette Durham, MD Professor of Radiology University of Colorado School of Medicine Introduce regional therapy for mnet Arterial therapies Injection
More informationEfficacy and Safety of Percutaneous Transhepatic Portal Embolization with Dehydrated Ethanol
Send Orders for Reprints to reprints@benthamscience.org 22 The Open Medical Imaging Journal, 2014, 8, 22-28 Open Access Efficacy and Safety of Percutaneous Transhepatic Portal Embolization with Dehydrated
More informationCholangiocarcinoma (Bile Duct Cancer)
Cholangiocarcinoma (Bile Duct Cancer) The Bile Duct System (Biliary Tract) A network of bile ducts (tubes) connects the liver and the gallbladder to the small intestine. This network begins in the liver
More informationVascular Complications of Hepatic Artery After Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinoma
Vascular and Interventional Radiology Pictorial Essay Sueyoshi et al. TE in Hepatocellular arcinoma Downloaded from www.ajronline.org by 37.44.199.42 on 02/04/18 from IP address 37.44.199.42. opyright
More informationEarly Infectious Complications of Percutaneous Metallic Stent Insertion for Malignant Biliary Obstruction
Vascular and Interventional Radiology Original Research Sol et al. Stent Insertion in Biliary Obstruction Vascular and Interventional Radiology Original Research Yu Li Sol 1 Chang Won Kim 1 Ung Bae Jeon
More informationPercutaneous Transarterial Embolization of Pseudoaneurysm Secondary to Pancreatitis: a case report
Chin J Radiol 2003; 28: 347-351 347 Percutaneous Transarterial Embolization of Pseudoaneurysm Secondary to Pancreatitis: a case report HSIN-YI LAI YUNG-FANG CHEN HSEIN-JAR CHIANG WU-CHUNG SHEN Department
More informationGeneral Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons
General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons MODULE TITLE: UPPER GI & HPB - HEPATIC, PANCREATIC & BILIARY
More informationDEB-TACE vs Conventional TACE in Intermediate HCC: Best Candidates for DEB-TACE?
DEB-TACE vs Conventional TACE in Intermediate HCC: Best Candidates for DEB-TACE? Ho Jong Chun, MD., PhD Seoul St. Mary s Hospital, The Catholic University of Korea Why Drug-eluting Beads? Clear Rationale
More informationpitfall Table 1 4 disorientation pitfall pitfall Table 1 Tel:
11 687 692 2002 pitfall 1078 29 17 9 1 2 3 dislocation outflow block 11 1 2 3 9 1 2 3 4 disorientation pitfall 11 687 692 2002 Tel: 075-751-3606 606-8507 54 2001 8 27 2002 10 31 29 4 pitfall 16 1078 Table
More informationLiver Tumors. Patient Education. Treatment options 8 4A. About the Liver. Surgical Specialties
Patient Education Treatment options This handout describes different kinds of tumors that form in the liver and how they are treated. About the Liver Your liver is the largest organ in your abdomen. It
More informationRuolo della interventistica per le secondarietà epatiche e di altre sedi
Ruolo della interventistica per le secondarietà epatiche e di altre sedi Giancarlo Bizzarri Dipartimento di Diagnostica per Immagini e Radiologia Interventistica Ospedale Regina Apostolorum, Albano Laziale
More informationLiver Cancer: Diagnosis and Treatment Options
Liver Cancer: Diagnosis and Treatment Options Fred Poordad, MD Chief, Hepatology University Transplant Center Professor of Medicine UT Health, San Antonio VP, Academic and Clinical Affairs, Texas Liver
More informationLiver and Pancreatic Case discussion
The Royal Marsden Liver and Pancreatic Case discussion Dr Ian Chau Consultant Medical Oncologist The Royal Marsden 77 year old gentleman with 2 months history of vague abdominal ache and clinically finding
More informationHepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center
Hepatocellular Carcinoma: A major global health problem David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center Hepatocellular Carcinoma WORLDWIDE The #2 Cancer Killer Overall cancer
More informationAppendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound
EFSUMB Newsletter 87 Examinations should encompass the full range of pathological conditions listed below A log book listing the types of examinations undertaken should be kept Training should usually
More informationCurrent Treatment of Colorectal Metastases. Dr. Thavanathan Surgical Grand Rounds February 1, 2005
Current Treatment of Colorectal Metastases Dr. Thavanathan Surgical Grand Rounds February 1, 2005 25% will have metastases at initial presentation 25-50% 50% will develop metastases later 40% of potentially
More informationTransarterial Chemoembolisation (TACE) with Drug-Eluting Beads
Transarterial Chemoembolisation (TACE) with Drug-Eluting Beads A minimally invasive treatment for liver cancer Provided as an educational service by Biocompatibles UK Ltd, a BTG International group company
More informationULTRA FLUID. Lipiodol efficacy & safety. for improved overall survival in HCC. Localization. Vectorization. Visualization. Chemo-Embolization
Ethyl ester of iodized fatty acids of poppy seed oil ULTRA FLUID Lipiodol efficacy & safety 1,2,3,4 for improved overall survival in HCC Localization Endorsed by International HCC Treatment Guidelines
More informationGASTROINTESTINAL IMAGING STUDY GUIDE
GASTROINTESTINAL IMAGING STUDY GUIDE Pharynx Diverticula Foreign bodies Trauma o Motility Disorders Esophagus Diverticula Trauma Esophagitis Barrett esophagus Rings, webs, and strictures Varices Benign
More informationHilar cholangiocarcinoma. Frank Wessels, Maarten van Leeuwen, UMCU utrecht
Hilar cholangiocarcinoma Frank Wessels, Maarten van Leeuwen, UMCU utrecht Content Anatomy Biliary strictures (Hilar) Cholangiocarcinoom Staging Biliary tract 1 st order Ductus hepatica dextra Ductus hepaticus
More informationIn any operation. Indications. Anaesthesia. Position of the patient. Incision. Steps of the operation. Complications.
In any operation Indications. Anaesthesia. Position of the patient. Incision. Steps of the operation. Complications. Abdominal operation I position for operation Supine Abdominal operation I position for
More informationManagement of Gallbladder Disease
Management of Gallbladder Disease Steven B. Johnson, MD, FACS, FCCM Professor and Chairman, Department of Surgery Program Director, Phoenix Integrated Surgical Residency University of Arizona College of
More informationFeasibility Study of Transcatheter Arterial Chemoembolization with Epirubicin Drug-eluting Beads for Hepatocellular Carcinoma in Japanese Patients
Original Research Feasibility Study of Transcatheter Arterial Chemoembolization with Epirubicin Drug-eluting Beads for Hepatocellular Carcinoma in Japanese Patients 1) Department of Diagnostic Radiology,
More informationHepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary)
Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary) Staff Reviewers: Dr. Yoo Joung Ko (Medical Oncologist, Sunnybrook Odette Cancer
More informationACUTE CHOLANGITIS AS a result of an occluded
Digestive Endoscopy 2017; 29 (Suppl. 2): 88 93 doi: 10.1111/den.12836 Current status of biliary drainage strategy for acute cholangitis Endoscopic treatment for acute cholangitis with common bile duct
More informationUrinary tract embolization
Beograd, 14.10.2012 Urinary tract embolization asist. Peter Popovič, MD, MSc Head of abdominal radiology department, Institute of Radiology, UMC Ljubljana Embolization Who and when procedure: local/general
More informationACUTE PANCREATITIS: NEW CLASSIFICATION OF AN OLD FOE. T Barrow, A Nasrullah, S Liong, V Rudralingam, S A Sukumar
ACUTE PANCREATITIS: NEW CLASSIFICATION OF AN OLD FOE T Barrow, A Nasrullah, S Liong, V Rudralingam, S A Sukumar LEARNING OBJECTIVES q Through a series of cases illustrate the updated Atlanta symposium
More informationis based on the fact that HCCs are exclusively supplied by the hepatic artery. When a tumor is advanced in stage
Hepatocellular Carcinoma with Internal Mammary Artery Supply: Feasibility and Efficacy of Transarterial Chemoembolization and Factors Affecting Patient Prognosis Hyo-Cheol Kim, MD, Jin Wook Chung, MD,
More informationMANAGEMENT OF PYOGENIC LIVER ABSCESS BOYOUNG SONG, M.D. SUNY DOWNSTATE SURGERY 11/7/13
MANAGEMENT OF PYOGENIC LIVER ABSCESS BOYOUNG SONG, M.D. SUNY DOWNSTATE SURGERY 11/7/13 CASE THE PATIENT IS A 79 YEAR OLD MALE WITH 3 DAY HISTORY OF LOWER ABDOMINAL PAIN, NAUSEA WITHOUT VOMITING, CHILLS
More informationLiver Directed Therapy for Hepatocellular Carcinoma
Liver Directed Therapy for Hepatocellular Carcinoma Anil K Pillai MD, FRCR, Associate Professor, Department of Radiology UT Houston Health Science Center, Houston, TX, United States. Hepatocellular cancer
More informationThe Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma Sung Wook Shin, MD Index terms: Carcinoma, hepatocellular Chemoembolization, therapeutic Iodized oil
More informationA LEADER IN ADVANCED ENDOSCOPY AND HEPATOBILIARY SURGERY
A LEADER IN ADVANCED ENDOSCOPY AND HEPATOBILIARY SURGERY St. Peter s Hospital Advanced Endoscopy & Hepatobiliary Center Welcome The St. Peter s Hospital Advanced Endoscopy & Hepatobiliary Center is a leader
More informationKenneth L. Croutch, * R q L. Gordon, * Ernest J. Ring, * Robert K. Kerlan Jr., * Jeanne M. LclBerge, * andjohn P. Roberts t. Patients and Methods
Superselective Arterial Embolization in the liver Transplant Recipient: A Safe Treatment for Hemobilia Caused by Percutaneous Transhepatic Biliary Drainage Kenneth L. Croutch, * R q L. Gordon, * Ernest
More informationIMAGING OF LIVER, BILIARY TREE, PANCREAS
IMAGING OF LIVER, BILIARY TREE, PANCREAS Department of Radiology West China Hospital, Sichuan University Yao Jin Learning Points The methodology for imaging the LBP (liver, biliary tree, and pancreas )
More informationMANAGEMENT OF BILATERAL ADRENAL METASTASES
Management of adrenal metastases from HCC MANAGEMENT OF BILATERAL ADRENAL METASTASES FROM HEPATOCELLULAR CARCINOMA: A CASE REPORT Meng-Hsuan Hsieh, Zu-Yau Lin, Chih-Jen Huang, 1 Ming-Chen Shih, 2 and Wan-Long
More informationMULTI-DISCIPLINARY MANAGEMENT OF INTERMEDIATE STAGE HCC
Dr Apoorva Gogna MBBS FRCR FAMS Consultant Interventional Radiology Center Department of Diagnostic Radiology SingaporeGeneral Hospital MULTI-DISCIPLINARY MANAGEMENT OF INTERMEDIATE STAGE HCC CASE HISTORY
More informationBILIARY TRACT & PANCREAS, PART II
CME Pretest BILIARY TRACT & PANCREAS, PART II VOLUME 41 1 2015 A pretest is mandatory to earn CME credit on the posttest. The pretest should be completed BEFORE reading the overview. Both tests must be
More informationCase Scenario 1. Discharge Summary
Case Scenario 1 Discharge Summary A 69-year-old woman was on vacation and noted that she was becoming jaundiced. Two months prior to leaving on that trip, she had had a workup that included an abdominal
More informationThe role for contrast-enhanced ultrasonography outside of focal liver lesions
The role for contrast-enhanced ultrasonography outside of focal liver lesions Paul S. Sidhu King s College Hospital, London, UK Introduction Contrast-enhanced ultrasonography (US) of focal liver lesions
More informationBile Duct Injury during Lap Chole. Bile Duct Injury during cholecystectomy TOPICS. 1. Prevalence, mechanisms, prevention and diagnosis
Bile Duct Injury during cholecystectomy Catherine HUBERT Jean-Fran François GIGOT Benoît t NAVEZ Division of Hepato-Biliary Biliary-Pancreatic Surgery Department of Abdominal Surgery and Transplantation
More informationDisclosures. Extra-hepatic Biliary Disease and the Pancreas. Objectives. Pancreatitis 10/3/2018. No relevant financial disclosures to report
Extra-hepatic Biliary Disease and the Pancreas Disclosures No relevant financial disclosures to report Jeffrey Coughenour MD FACS Clinical Associate Professor of Surgery and Emergency Medicine Division
More informationPANCREATIC CANCER GUIDELINES
PANCREATIC CANCER GUIDELINES North-East London Cancer Network & Barts and the London HPB Centre PROTOCOL FOR MANAGEMENT OF PANCREATIC CANCER (SEPTEMBER 2010) I. PRE-REFERRAL GUIDELINES Screening 1. Offer
More informationGeneral Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons
General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons MODULE TITLE: UPPER GI & HPB - HEPATIC, PANCREATIC & BILIARY
More informationMANAGEMENT RECOMMENDATIONS
1 MANAGEMENT RECOMMENDATIONS 1. Adrenal masses!!!!!!! page 2 2. Liver Masses!!!!!!! page 3 3. Obstetric US Soft Markers for Aneuploidy!! pages 4-6 4. Ovarian and Adnexal Cysts!!!!! pages 7-10 5. Pancreatic
More informationManagement of Colorectal Liver Metastases
Management of Colorectal Liver Metastases MM Bernon, JEJ Krige HPB Surgical Unit, Groote Schuur Hospital Department of Surgery, University of Cape Town 50% of patients with colorectal cancer develop liver
More informationInterventional radiology
Interventional radiology Nonvascular Doros Attila MD, Semmelweis Univ. Dept.of Transplantation and Surgery Radiology med IR/MIT Attempted non surgical invasive therapy with good results (sometimes as good
More informationRole of loco-regional treatment in the medical and surgical management strategy of metastatic colorectal cancer
Role of loco-regional treatment in the medical and surgical management strategy of metastatic colorectal cancer M Ducreux, MD, PhD Gustave Roussy Villejuif, FRANCE M Ducreux is a consultant to Biocompatibles
More informationHCC Imaging and Advances in Locoregional Therapy. David S. Kirsch MD Ochsner Clinic Foundation
HCC Imaging and Advances in Locoregional Therapy David S. Kirsch MD Ochsner Clinic Foundation -Nothing to disclose Hepatic Imaging Primary imaging modalities include: US CT MR Angiography Nuclear medicine
More informationSurgical anatomy of the biliary tract
HPB, 2008; 10: 7276 REVIEW ARTICLE Surgical anatomy of the biliary tract DENIS CASTAING Centre hépato-biliaire, Hôpital Paul Brousse, Assistance Publique- Hôpitaux de Paris, Université Paris XI, Paris,
More informationINTRAARTERIAL TREATMENT OF COLORECTAL LIVER METASTASES. Dr. Joan Falcó Interventional Radiology UDIAT. Hospital Universitari Parc Taulí
INTRAARTERIAL TREATMENT OF COLORECTAL LIVER METASTASES Dr. Joan Falcó Interventional Radiology UDIAT. Hospital Universitari Parc Taulí STRATEGIES FOR CRLM LIVER METASTASES Extended indications Resectable
More informationBronchobiliary fistula treated with histoacryl embolization under bronchoscopic guidance: A case report
Respiratory Medicine CME (2008) 1, 164 168 respiratory MEDICINE CME CASE REPORT Bronchobiliary fistula treated with histoacryl embolization under bronchoscopic guidance: A case report Jung Hyun Kim a,
More informationInterventional Radiology Original Research
Interventional Radiology Original Research Seki et al. Side-Hole Catheter Placement for HAI Chemotherapy Interventional Radiology Original Research Hiroshi Seki 1 Toshirou Ozaki Makoto Shiina Seki H, Ozaki
More informationCholangiocarcinoma. GI Practice Guideline. Michael Sanatani, MD, FRCPC (Medical Oncologist) Barbara Fisher, MD, FRCPC (Radiation Oncologist)
Cholangiocarcinoma GI Practice Guideline Michael Sanatani, MD, FRCPC (Medical Oncologist) Barbara Fisher, MD, FRCPC (Radiation Oncologist) Approval Date: October 2006 This guideline is a statement of consensus
More informationInterventional Radiologic Treatment of Hepatocellular Carcinoma
Interventional Radiologic Treatment of Hepatocellular Carcinoma Fatih Boyvat Abstract The current treatment modalities for patients with hepatocellular carcinoma are discussed in this review. Hepatocellular
More informationBiliary tree dilation - and now what?
Biliary tree dilation - and now what? Poster No.: C-1767 Congress: ECR 2012 Type: Educational Exhibit Authors: I. Ferreira, A. B. Ramos, S. Magalhães, M. Certo; Porto/PT Keywords: Pathology, Diagnostic
More informationHepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: Incidence, diagnosis, treatment, outcome and mechanism
Critical Reviews in Oncology/Hematology 79 (2011) 164 174 Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: Incidence, diagnosis, treatment, outcome and mechanism
More informationLab Monitor Images Dissection of the Abdominal Vasculature + Lower Digestive System
Lab Monitor Images Dissection of the Abdominal Vasculature + Lower Digestive System Stomach & Duodenum Frontal (AP) View Nasogastric tube 2 1 3 4 Stomach Pylorus Duodenum 1 Duodenum 2 Duodenum 3 Duodenum
More information